Everybody had heard about Melanoma, which is one type of skin cancer is caused by overexposure to the sun. Every year nearly 9,000 Americans die due to the Melanoma.
Recently researches were Going out to control cancer in the final stage is giving a hope for patients suffering from Melanoma.
“It’s really the most optimistic time I’ve ever seen for patients with advanced melanoma.” Said by the Dr. Lynn Schuchter from University of Pennsylvania Hospital.
Normally melanoma patients have a gene that exactly promotes growth of cancer. They were to trying to disrupt the gene by using pills, which helps in shrinking the gene. It also had been perfectly tested on nearly 80 percent of patients who are having cancer and carrying the gene, increased the lifetime of patients more than seven months.
“Compared to chemotherapy, it works much better in melanoma and it has less side effects” as it was said by Dr. Antoni Ribas, of UCLA’s Jonsson Comprehensive Cancer Cente.
After taking the drug Shirley who was suffering from Melanoma cancer got a strong hope to live more, further she does not expect to be alive today .Before 11 months doctors had informed her that she is in last stage of cancer will die soon. Drug helped her to live more.
Related tags
• melanoma pill • new pill for melanoma • melanoma pills • pills for melanoma • Toni Ribas MD • pill for melanoma • melanoma cancer pill • preventive melanoma pill • melanoma ucla anthony ribas • toni ribas ucla • what is the name of the latest pill for melanomaRelated posts:
- FDA Approved New pillFinally, FDA had approved one pill named Ella which is...
- The Pill which Replaces Sunscreen Lotions: The effect May Last for Many WeeksBritish scientists found the solution for you if you enjoy...
- Liquid Vitamins or Pill VitaminsWhen it comes to choosing liquid vitamins or pill vitamins...
- Tanning beds lead to the appearance of skin cancerTanning beds are a well-known and used by almost all...
- FDA approves of a new Mini Dose birth control pillThe Food and Drug Administration or FDA has now approved...




